Patients Views & Analysis

Views & Analysis

boost-drug-development-in-orphan-diseases

Joined up thinking and innovation will boost drug developmen...

Fresh thinking and greater collaboration at the European level could accelerate the much-needed development of treatments and cures for children with rare diseases.

Views & Analysis

Where next for patient centricity in pharma?

As patient centricity seems to be hitting a slump, Paul Tunnah lays out the key factors companies need to consider to deliver on its promises.

Views & Analysis

Whitepaper-provides-a-blueprint-to-building-a-patient-centric-company

A blueprint for building a patient-centric pharma company

While the industry appears united in its commitment to patient centricity, the practicalities of embedding the ethos into everyday work is still hotly debated.

Views & Analysis

FCS: A life-limiting condition

GP Karishma Patel tells us about the daily challenges of living with the ultra-rare condition Familial Chylomicronaemia Syndrome (FCS), which prevents the body from breaking down fats.

Views & Analysis

eyeforpharma Patient Summit Europe roundup

eyeforpharma's Patient Summit Europe brought together leading patient innovators from industry and patient associations for two days of sharing, learning and a healthy dose

Views & Analysis